These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37857431)

  • 21. "Spatial transcriptomics for respiratory research and medicine." S. Curras-Alonso, J. Soulier, T. Walter,
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36822638
    [No Abstract]   [Full Text] [Related]  

  • 22. "Impact of hepatopulmonary syndrome in liver transplantation candidates and the role of angiogenesis." S.M. Kawut, M.J. Krowka, K.A. Forde, N. Al-Naamani, K.L. Krok, M. Patel, C.R. Bartoli, M. Doyle, J. Moutchia, G. Lin, J.K. Oh, C.D. Mottram, P.D. Scanlon and M.B. Fallon for the Pulmonary Vascular Complications of Liver Disease Study Group.
    Eur Respir J; 2023 Jul; 62(1):. PubMed ID: 37500111
    [No Abstract]   [Full Text] [Related]  

  • 23. "Number needed to treat: enigmatic results for exacerbations in COPD." Samy Suissa.
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29903826
    [No Abstract]   [Full Text] [Related]  

  • 24. First Report of Dickeya dianthicola causing blackleg on New Guinea Impatiens (Impatiens hawkeri) in New York State, USA.
    Liu Y; Vasiu S; Daughtrey ML; Filiatrault M
    Plant Dis; 2020 Nov; ():. PubMed ID: 33200972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis." Nikhil Hirani, Alison C. MacKinnon, Lisa Nicol,
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35422427
    [No Abstract]   [Full Text] [Related]  

  • 26. "Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs." A. Jouet, C. Gaudin, N. Badalato,
    Eur Respir J; 2022 Nov; 60(5):. PubMed ID: 36356977
    [No Abstract]   [Full Text] [Related]  

  • 27. Are the Effects of High-Intensity Exercise Training Different in Patients with COPD Versus COPD+Asthma Overlap?
    Rodrigues A; de Oliveira JM; Furlanetto KC; Machado FVC; Belo LF; Schneider LP; Morita AA; Andrelo AC; Fonseca J; Brito IL; Paes T; Felcar JM; Probst VS; Hernandes NA; Pitta F
    Lung; 2020 Feb; 198(1):135-141. PubMed ID: 31873783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of chronic kidney disease among Korean adults with chronic obstructive pulmonary disease.
    Kim MY; Boo S; Yoo M; Lee J; Kang NR
    Int Urol Nephrol; 2017 Jul; 49(7):1225-1232. PubMed ID: 28386744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis." A. Campredon, E. Battistella, C. Martin,
    Eur Respir J; 2023 Mar; 61(3):. PubMed ID: 36997234
    [No Abstract]   [Full Text] [Related]  

  • 30. Progression and prognostic indicators of bronchial disease in children with sickle cell disease.
    Williams SN; Nussbaum E; Yoonessi L; Morphew T; Randhawa I
    Lung; 2014 Jun; 192(3):385-93. PubMed ID: 24699774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline." James D. Chalmers, Megan L. Crichton, Pieter C. Goeminne,
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35948349
    [No Abstract]   [Full Text] [Related]  

  • 32. "Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages." K. Hönzke, B. Obermayer, C. Mache,
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36758997
    [No Abstract]   [Full Text] [Related]  

  • 33. "Normative data for multiple breath washout outcomes in school-aged Caucasian children." Pinelopi Anagnostopoulou, Philipp Latzin, Renee Jensen,
    Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35981729
    [No Abstract]   [Full Text] [Related]  

  • 34. "Interstitial lung abnormalities are associated with decreased mean telomere length." R.K. Putman, G.T. Axelsson, S.Y. Ash,
    Eur Respir J; 2023 Sep; 62(3):. PubMed ID: 37690790
    [No Abstract]   [Full Text] [Related]  

  • 35. "Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension." Mark Toshner, Colin Church, Lars Harbaum,
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 35798371
    [No Abstract]   [Full Text] [Related]  

  • 36. Interstitial Lung Disease in ANCA-Associated Vasculitis: Pathogenic Considerations and Impact for Patients' Outcomes.
    Sun K; Fisher JH; Pagnoux C
    Curr Rheumatol Rep; 2022 Aug; 24(8):259-267. PubMed ID: 35794350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek,
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 35680153
    [No Abstract]   [Full Text] [Related]  

  • 38. "Cellular sources of interleukin-6 and associations with clinical phenotypes and outcomes in pulmonary arterial hypertension." Catherine E. Simpson, Jenny Y. Chen, Rachel L. Damico,
    Eur Respir J; 2022 Apr; 59(4):. PubMed ID: 35484798
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
    Tang YC; Thoman M; Linton PJ; Deisseroth A
    Cancer Immunol Immunother; 2009 Dec; 58(12):1949-57. PubMed ID: 19444444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Cardiovascular disease and COPD: dangerous liaisons." Klaus F. Rabe, John R. Hurst and Samy Suissa.
    Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30463874
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.